US 12,465,778 B2
Multimodal device and method to increase the efficacy of transthoracic cardioversion or cardiac pacing in patients with perfusing rhythms
Norman Alan Paradis, Putney, VT (US)
Filed by Norman Alan Paradis, Putney, VT (US)
Filed on Sep. 9, 2022, as Appl. No. 17/942,041.
Application 17/942,041 is a continuation in part of application No. 17/676,612, filed on Feb. 21, 2022, granted, now 12,285,621.
Application 17/676,612 is a continuation of application No. 16/514,968, filed on Jul. 17, 2019, granted, now 11,253,713.
Claims priority of provisional application 62/699,647, filed on Jul. 17, 2018.
Prior Publication US 2023/0001220 A1, Jan. 5, 2023
Int. Cl. A61N 1/00 (2006.01); A61H 31/00 (2006.01); A61N 1/39 (2006.01)
CPC A61N 1/39044 (2017.08) [A61H 31/005 (2013.01)] 20 Claims
OG exemplary drawing
 
1. A Cardiac Electrical Therapy Efficacy Enhancement System (CETEES) to improve the efficacy of acute electrical therapies for patients suffering cardiac dysrhythmias with retained hemodynamics, the CETEES comprising:
a Transthoracic Cardioverter Pacer (TCP);
an electrode contact force enhancers adapted to press on a TCP electrode;
a controller that synchronizes the TCP and the electrode contact force enhancer so that the TCP administers an electrical discharge in synchrony with the application of force to the TCP electrode by the electrode contact force enhancer; and
an inelastic outer shell adapted to contain and maintain the location of the electrode contact force enhancers and provide a Newtonian counterforce that allows the electrode contact force enhancer to apply inward force towards the center of the CETEES.